CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS. (2021)
Attributed to:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.70342
Publication URI: https://www.repository.cam.ac.uk/handle/1810/322886
Type: Journal Article/Review